CEO Buys GHC.MI Stock After Temporary Earnings Drop
GHC.MI stock analysis: 18% sales CAGR at 9.5x EBITDA — buy or sell valuation deep dive 👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_podcast&utm_medium=podcast&utm_campaign=freja_and_friends In this deep dive, we break down Garofalo Health Care S.p.A. (GHC.MI) and its highly resilient buy-and-build M&A model consolidating Italy's fragmented healthcare sector. With shares trading at a defensive 9.57x trailing EV/EBITDA multiple and the company's 5-year sales CAGR expanding at 18.23%, the key question for…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.